Insulin inhibits its own secretion from isolated, perifused human pancreatic islets. 1995

P Marchetti, and D W Scharp, and M McLear, and E H Finke, and B Olack, and C Swanson, and R Giannarelli, and R Navalesi, and P E Lacy
Department of Metabolic Diseases, University of Pisa, Italy.

It is still a controversial question whether insulin suppresses its own secretion. We prepared pure human islets from three pancreases by collagenase digestion and density gradient purification. Aliquots of 200 islet equivalents (IE, 150-microns sized-islets) were sequentially perifused at 37 degrees C with 3.3 mmol/l glucose (3.3G, 40 min), 16.7 mmol/l glucose (16.7G, 30 min) and again 3.3G (30 min) after 24 h, 37 degrees C culture in CMRL 1066 medium with or without the addition of either 200 or 400 microU/ml human insulin in the incubation medium (6 replicates each). Insulin secretion was assessed by C-peptide (Cp) measurement in the perifusate. Without added insulin (C) and with 200 (Ins200) or 400 (Ins400) microU/ml added insulin, basal Cp release was 0.12 +/- 0.03, 0.14 +/- 0.02 and 0.14 +/- 0.04 ng/ml, respectively. At 16.7G, the first-phase secretion peak (expressed as Cp value) was significantly lower with Ins200 (0.47 +/- 0.13 ng/ml, P < 0.02) and Ins400 (0.68 +/- 0.15 ng/ml, P < 0.05) than C (0.83 +/- 0.15 ng/ml). The second-phase secretion peak was also significantly (P < 0.05) reduced with added insulin (Ins200: 0.47 +/- 0.08 ng/ml; Ins400: 0.45 +/- 0.07 ng/ml) than in its absence (C: 0.65 +/- 0.09 ng/ml). Accordingly, total Cp secretion was lower with Ins200 (10.6 +/- 2.3 ng/ml, P = 0.03) and Ins400 (11.8 +/- 2.3 ng/ml) than with C (16.0 +/- 2.2 ng/ml).(ABSTRACT TRUNCATED AT 250 WORDS)

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D007515 Islets of Langerhans Irregular microscopic structures consisting of cords of endocrine cells that are scattered throughout the PANCREAS among the exocrine acini. Each islet is surrounded by connective tissue fibers and penetrated by a network of capillaries. There are four major cell types. The most abundant beta cells (50-80%) secrete INSULIN. Alpha cells (5-20%) secrete GLUCAGON. PP cells (10-35%) secrete PANCREATIC POLYPEPTIDE. Delta cells (~5%) secrete SOMATOSTATIN. Islands of Langerhans,Islet Cells,Nesidioblasts,Pancreas, Endocrine,Pancreatic Islets,Cell, Islet,Cells, Islet,Endocrine Pancreas,Islet Cell,Islet, Pancreatic,Islets, Pancreatic,Langerhans Islands,Langerhans Islets,Nesidioblast,Pancreatic Islet
D007700 Kinetics The rate dynamics in chemical or physical systems.
D010477 Perfusion Treatment process involving the injection of fluid into an organ or tissue. Perfusions
D002096 C-Peptide The middle segment of proinsulin that is between the N-terminal B-chain and the C-terminal A-chain. It is a pancreatic peptide of about 31 residues, depending on the species. Upon proteolytic cleavage of proinsulin, equimolar INSULIN and C-peptide are released. C-peptide immunoassay has been used to assess pancreatic beta cell function in diabetic patients with circulating insulin antibodies or exogenous insulin. Half-life of C-peptide is 30 min, almost 8 times that of insulin. Proinsulin C-Peptide,C-Peptide, Proinsulin,Connecting Peptide,C Peptide,C Peptide, Proinsulin,Proinsulin C Peptide
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D005246 Feedback A mechanism of communication within a system in that the input signal generates an output response which returns to influence the continued activity or productivity of that system. Feedbacks
D005947 Glucose A primary source of energy for living organisms. It is naturally occurring and is found in fruits and other parts of plants in its free state. It is used therapeutically in fluid and nutrient replacement. Dextrose,Anhydrous Dextrose,D-Glucose,Glucose Monohydrate,Glucose, (DL)-Isomer,Glucose, (alpha-D)-Isomer,Glucose, (beta-D)-Isomer,D Glucose,Dextrose, Anhydrous,Monohydrate, Glucose
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

P Marchetti, and D W Scharp, and M McLear, and E H Finke, and B Olack, and C Swanson, and R Giannarelli, and R Navalesi, and P E Lacy
September 1994, Acta diabetologica,
P Marchetti, and D W Scharp, and M McLear, and E H Finke, and B Olack, and C Swanson, and R Giannarelli, and R Navalesi, and P E Lacy
October 1986, Diabetes,
P Marchetti, and D W Scharp, and M McLear, and E H Finke, and B Olack, and C Swanson, and R Giannarelli, and R Navalesi, and P E Lacy
July 1998, Cellular and molecular life sciences : CMLS,
P Marchetti, and D W Scharp, and M McLear, and E H Finke, and B Olack, and C Swanson, and R Giannarelli, and R Navalesi, and P E Lacy
March 1989, Endocrinology,
P Marchetti, and D W Scharp, and M McLear, and E H Finke, and B Olack, and C Swanson, and R Giannarelli, and R Navalesi, and P E Lacy
February 1989, Nihon Ika Daigaku zasshi,
P Marchetti, and D W Scharp, and M McLear, and E H Finke, and B Olack, and C Swanson, and R Giannarelli, and R Navalesi, and P E Lacy
October 1989, The American journal of physiology,
P Marchetti, and D W Scharp, and M McLear, and E H Finke, and B Olack, and C Swanson, and R Giannarelli, and R Navalesi, and P E Lacy
November 1997, European journal of pharmacology,
P Marchetti, and D W Scharp, and M McLear, and E H Finke, and B Olack, and C Swanson, and R Giannarelli, and R Navalesi, and P E Lacy
December 1993, British journal of anaesthesia,
P Marchetti, and D W Scharp, and M McLear, and E H Finke, and B Olack, and C Swanson, and R Giannarelli, and R Navalesi, and P E Lacy
August 1986, Endocrinology,
P Marchetti, and D W Scharp, and M McLear, and E H Finke, and B Olack, and C Swanson, and R Giannarelli, and R Navalesi, and P E Lacy
June 1981, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,
Copied contents to your clipboard!